Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Oslo, Norway, March 4, 2024 - Primary insider Harald Gurvin, Chief Financial
Officer of Nykode Therapeutics ASA, has today acquired 20,000 shares in Nykode
Therapeutics ASA at an average price of NOK 16.59 per share.
Please see further details in the attached document.